DOCS.NYSEDoximity, INC

Form 4: Doximity Insider Trades Class A Stock

Sentiment:

Statement of Changes in Beneficial Ownership


Doximity Inc. reports insider transactions involving Class A common stock, including option exercises and sales under a 10b5-1 plan.

Summary

  • Sitaram Siddharth, Interim PFO and PAO at Doximity, Inc., reported transactions on April 10, 2026.
  • Acquired 5,000 shares of Class A Common Stock via option exercise.
  • Sold 2,427 shares of Class A Common Stock to cover tax withholding obligations related to the option exercise.
  • The sales were executed automatically under a Rule 10b5-1 trading plan adopted on August 28, 2025.
  • Class B Common Stock held by the reporting person is convertible into Class A Common Stock under specific conditions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine insider transactions executed under a pre-established plan, rather than indicating significant new strategic developments or financial performance shifts.

Positives

  • The reporting person exercised stock options, indicating potential alignment with company performance.
  • A Rule 10b5-1 plan is in place, suggesting pre-planned and potentially less market-sensitive trading activity.
  • The company has a clear structure for Class B to Class A common stock conversion.

Negatives

  • Sale of shares to cover tax withholding obligations implies a need to liquidate some holdings.
  • The exact net change in beneficial ownership after the exercise and sale is not explicitly stated as a positive or negative, but represents a reduction in direct holdings of exercised options.

Risks

  • The Rule 10b5-1 plan is subject to specific conditions and could be impacted by changes in market conditions or company performance.
  • Future sales under the 10b5-1 plan could potentially impact stock price if executed in large volumes.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance regarding future financial performance. It primarily details past transactions.

Management Comments

  • The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2025.
  • Represents shares of Class A Common Stock sold by the Reporting Person in a sell-to-cover transaction to satisfy the tax withholding obligations in connection with the exercise of a stock option previously granted to the Reporting Person.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those under Rule 10b5-1 plans, are common in the technology and healthcare sectors as companies utilize equity-based compensation. Doximity operates in the digital health space, where such compensation structures are prevalent.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Interim PFO and PAON/ASitaram SiddharthN/AN/A

Stakeholder Impact

  • Shareholders: The transactions are executed under a pre-defined plan, minimizing immediate impact, but future sales could influence supply.
  • Employees: The reporting person's actions reflect standard executive compensation practices.
  • Management: Demonstrates adherence to disclosure requirements and established trading policies.

Next Steps

  • Continued vesting of stock options as per the original grant schedule.
  • Potential future transactions under the Rule 10b5-1 plan, subject to its terms and market conditions.

Key Dates

DateDescription
2020-12-22Date stock option was granted.
2021-11-23First vesting date for stock options (1/4th of total shares).
2025-08-28Date Rule 10b5-1 trading plan was adopted.
2026-04-10Transaction date for option exercise and stock sale.
2026-04-14Date of filing signature.
2030-12-21Expiration date of the stock option.

Keywords

Doximity, DOCS, Form 4, Insider Trading, Stock Options, Class A Common Stock, Class B Common Stock, Rule 10b5-1, Tax Withholding, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.